Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer Article

cited authors

  • Maxwell-Armstrong, CA; Durrant, LG; Buckley, TJD; Scholefield, JH; Robins, RA; Fielding, K; Monson, JRT; Guillou, P; Calvert, H; Carmichael, J; Hardcastle, JD

authors

Publication Date

  • June 1, 2001

webpage

published in

category

keywords

  • 105AD7
  • anti-idiotypic antibody
  • colorectal cancer
  • immunotherapy

start page

  • 1443

end page

  • 1446

volume

  • 84

issue

  • 11